Assessment of KM-001 – Safety, Tolerability, and Efficacy in Patients With PPPK1 or PC
Condition(s):Punctate Palmoplantar Keratoderma Type 1; Pachyonychia CongenitaLast Updated:July 25, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Punctate Palmoplantar Keratoderma Type 1; Pachyonychia CongenitaLast Updated:July 25, 2023Recruiting
Condition(s):Systemic Lupus Erythematosus; Lichen PlanusLast Updated:April 21, 2020Unknown status
Condition(s):KPPP1; Pachyonychia, CongenitalLast Updated:July 18, 2023Recruiting
Condition(s):Basal Cell Carcinoma; Keratosis Palmaris et Plantaris; PsoriasisLast Updated:March 4, 2008Completed
Condition(s):Ichthyosis; Palmoplantar Keratoses; Epidermolysis Bullosa; Ectodermal Dysplasia; Basal Cell Nevus Syndrome; Birt-Hogg-Dube Syndrome; Tuberous Sclerosis; Xeroderma Pigmentosum; Cutis Laxa; AlbinismLast Updated:March 26, 2024Enrolling by invitation
Condition(s):Quality of Life; Ichthyosis; Palmoplantar Keratoses; Epidermolysis Bullosa; Ectodermal Dysplasia; Basal Cell Nevus Syndrome; Birt-Hogg-Dube Syndrome; Tuberous Sclerosis; Cutis Laxa; AlbinismLast Updated:March 26, 2024Recruiting
Condition(s):Inherited Epidermolysis Bullosa; Ichthyosis; Ectodermal Dysplasia; Incontinentia Pigmenti; Neurofibromatosis Type 1; Albinism; Pemphigus; Mucous Membrane Pemphigoid; Palmoplantar KeratodermaLast Updated:July 20, 2023Recruiting
Condition(s):Papillon-Lefevre DiseaseLast Updated:March 24, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.